The role of nitric oxide in glutaric acid-induced convulsive behavior in pup rats

César Augusto Brüning1, Suzan Gonçalves Rosa2, Caroline Brandão Quines2

  • 1Laboratory of Biochemistry and Molecular Neuropharmacology (LABIONEM), Neurobiotechnology Research Group, Postgraduate Program in Biochemistry and Bioprospecting (PPGBBio), Center for Chemical, Pharmaceutical and Food Sciences (CCQFA), Federal University of Pelotas (UFPel), Pelotas, Brazil.

Insights

Nitric oxide (NO) contributes to seizures in Glutaric acidaemia type I (GA-I). Inhibiting NO synthesis reduced seizure duration and increased latency in rats, suggesting NO as a therapeutic target for this organic acidemia.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pediatric Organic Acidemias

Background:

  • Glutaric acidaemia type I (GA-I) is a rare metabolic disorder causing neurological damage and seizures due to glutaric acid accumulation.
  • The precise mechanisms underlying GA-I-induced seizures are not fully understood, necessitating further investigation.
  • Nitric oxide (NO) is implicated in various neurological processes, including seizure activity.

Purpose of the Study:

  • To investigate the role of nitric oxide (NO) in glutaric acid (GA)-induced seizures in a rat model of Glutaric acidaemia type I (GA-I).
  • To explore potential therapeutic strategies targeting NO pathways for managing neurological symptoms in GA-I.

Main Methods:

  • Intrastriatal administration of glutaric acid (GA) to 21-day-old male Wistar rats to induce seizures.
  • Administration of N-G-nitro-l-arginine methyl ester (L-NAME), a NO synthesis inhibitor, or saline (vehicle) prior to GA injection.
  • Measurement of seizure latency and duration, and analysis of striatal nitrate and nitrite (NOx) levels.

Main Results:

  • L-NAME significantly increased seizure latency and decreased seizure duration in GA-treated rats.
  • GA administration elevated striatal NOx levels, an effect attenuated by L-NAME pretreatment.
  • The NO precursor, l-arginine (L-ARG), reversed the effects of L-NAME, confirming NO's involvement.

Conclusions:

  • Nitric oxide (NO) plays a significant role in the pathogenesis of glutaric acid-induced seizures in young rats.
  • These findings provide experimental evidence supporting NO's contribution to the neurological manifestations of Glutaric acidaemia type I.
  • Targeting NO pathways may offer a novel therapeutic approach for managing seizures in GA-I patients.

Related Concept Videos